Butterfly Network (BFLY) Capital Expenditures Growth (1y) (2021 - 2026)
Butterfly Network (BFLY) Capital Expenditures Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.39 Bn | 174.10 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.38 Bn | 125.50 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 107.68 Bn | 98.46 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 67.98 Bn | 66.53 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 47.81 Bn | 44.13 Bn | 1.29 Bn | 15.89% |
| 6 | GE HealthCare Technologies | 28.53 Bn | 26.25 Bn | 1.98 Bn | 106.98% |
| 7 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | -11.95% |
| 8 | Smith & Nephew | 26.78 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.34 Bn | 22.21 Bn | 2.07 Bn | -47.73% |
| 10 | Butterfly Network | 1.76 Bn | 1.62 Bn | 18.29 Mn | 169.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 169.12% |
| Dec 31, 2025 | -558.09% |
| Sep 30, 2025 | 145.41% |
| Jun 30, 2025 | 22.07% |
| Mar 31, 2025 | -68.98% |
| Dec 31, 2024 | -83.76% |
| Sep 30, 2024 | -60.50% |
| Jun 30, 2024 | -16.69% |
| Mar 31, 2024 | -15.20% |
| Dec 31, 2023 | 121.51% |
| Sep 30, 2023 | -77.23% |
| Jun 30, 2023 | -87.54% |
| Mar 31, 2023 | -70.22% |
| Dec 31, 2022 | -388.30% |
| Sep 30, 2022 | 130.45% |
| Jun 30, 2022 | 1,209.63% |
| Mar 31, 2022 | 249.57% |
| Dec 31, 2021 | 1,933.03% |
| Sep 30, 2021 | 189.84% |
| Jun 30, 2021 | -62.18% |